Literature DB >> 15450250

Got RIP? Presenilin-dependent intramembrane proteolysis in growth factor receptor signaling.

Natalie Landman1, Tae-Wan Kim.   

Abstract

A number of cell surface growth factor receptors are subject to presenilin-dependent regulated intramembrane proteolysis (PS-RIP) after ligand binding and/or ectodomain cleavage. PS-RIP is mediated by a highly conserved multi-component membrane-bound protease, termed gamma-secretase, responsible for generating Alzheimer's disease (AD)-associated Abeta peptide from its membrane-bound beta-amyloid precursor protein (APP), as well as for cleaving a number of other type-I membrane receptors. PS-RIP is a conserved cellular process by which cells transmit signals from one compartment to another, including the liberation of membrane-bound transcription factors. Recent studies indicate that PS-RIP also mediates the proteolytic inactivation of heteromeric receptor complexes by removing the transmembrane domains required for receptor-receptor interaction. Thus, PS-RIP appears to regulate diverse cellular pathways either by generating soluble effectors from membrane-bound precursors, or by removing the transmembrane domain of a membrane-tethered signaling component.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15450250     DOI: 10.1016/j.cytogfr.2004.04.001

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  28 in total

1.  Tumour necrosis factor alpha-converting enzyme mediates ectodomain shedding of Vps10p-domain receptor family members.

Authors:  Guido Hermey; Susanne S Sjøgaard; Claus Munck Petersen; Anders Nykjaer; Jørgen Gliemann
Journal:  Biochem J       Date:  2006-04-15       Impact factor: 3.857

2.  An alternative interpretation of the amyloid Abeta hypothesis with regard to the pathogenesis of Alzheimer's disease.

Authors:  Vincent T Marchesi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-20       Impact factor: 11.205

3.  Down-regulation of the met receptor tyrosine kinase by presenilin-dependent regulated intramembrane proteolysis.

Authors:  Bénédicte Foveau; Frédéric Ancot; Catherine Leroy; Annalisa Petrelli; Karina Reiss; Valérie Vingtdeux; Silvia Giordano; Véronique Fafeur; David Tulasne
Journal:  Mol Biol Cell       Date:  2009-03-18       Impact factor: 4.138

4.  Membrane-tethered transcription factors provide a connection between stress response and developmental pathways.

Authors:  Erin Slabaugh; Federica Brandizzi
Journal:  Plant Signal Behav       Date:  2011-08-01

Review 5.  Phospholipase D in brain function and Alzheimer's disease.

Authors:  Tiago Gil Oliveira; Gilbert Di Paolo
Journal:  Biochim Biophys Acta       Date:  2010-04-23

6.  Sequential cleavage of insulin receptor by calpain 2 and γ-secretase impairs insulin signalling.

Authors:  Tomoyuki Yuasa; Kikuko Amo-Shiinoki; Shuhei Ishikura; Mitsuyoshi Takahara; Takaaki Matsuoka; Hideaki Kaneto; Akio Kuroda; Munehide Matsuhisa; Seiichi Hashida
Journal:  Diabetologia       Date:  2016-09-30       Impact factor: 10.122

7.  Nuclear translocation and signalling of L1-CAM in human carcinoma cells requires ADAM10 and presenilin/gamma-secretase activity.

Authors:  Svenja Riedle; Helena Kiefel; Daniela Gast; Sandra Bondong; Silke Wolterink; Paul Gutwein; Peter Altevogt
Journal:  Biochem J       Date:  2009-05-27       Impact factor: 3.857

8.  Differential modulation of TCF/LEF-1 activity by the soluble LRP6-ICD.

Authors:  Brandon Beagle; Gail V W Johnson
Journal:  PLoS One       Date:  2010-07-28       Impact factor: 3.240

9.  γ-Secretase inhibition promotes fibrotic effects of albumin in proximal tubular epithelial cells.

Authors:  C Slattery; Y Jang; W A Kruger; D H Hryciw; A Lee; P Poronnik
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

10.  Synaptic activity prompts gamma-secretase-mediated cleavage of EphA4 and dendritic spine formation.

Authors:  Eiji Inoue; Maki Deguchi-Tawarada; Aki Togawa; Chiyuki Matsui; Kohei Arita; Sayaka Katahira-Tayama; Toshitaka Sato; Emiko Yamauchi; Yoshiya Oda; Yoshimi Takai
Journal:  J Cell Biol       Date:  2009-05-04       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.